BTAIVSCRL• 3 Months (Normalized)
BTAI vs CRL (BioXcel Therapeutics Inc. vs Charles River Laboratories International Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
CRL Performance $290.19
+25.39%
Charles River Laboratories International Inc.
Normalized Baseline0.00%
Alpha Spread Margin CRL LEADS
-25.39 pts
CRL outperforming by 25.39 percentage points
BTAICRL
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI CRL
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(64 dates)
| Date | BTAI Price | BTAI Gain (%) | CRL Price | CRL Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $- | $290.19 | +25.39% | - | |
| Oct 01, 2026 | $- | $286.83 | +23.94% | - | |
| Sep 30, 2026 | $- | $295.01 | +27.47% | - | |
| Sep 29, 2026 | $- | $295.96 | +27.88% | - | |
| Sep 28, 2026 | $- | $294.59 | +27.29% | - | |
| Sep 25, 2026 | $- | $292.84 | +26.54% | - | |
| Sep 24, 2026 | $0.04 | -96.79% | $- | - | |
| Sep 23, 2026 | $0.05 | -95.91% | $277.33 | +19.83% | -115.74% |
| Sep 22, 2026 | $0.04 | -95.95% | $285.11 | +23.19% | -119.14% |
| Sep 21, 2026 | $0.06 | -94.41% | $279.01 | +20.56% | -114.97% |
| Sep 18, 2026 | $0.06 | -94.73% | $278.06 | +20.15% | -114.88% |
| Sep 17, 2026 | $0.08 | -93.17% | $281.67 | +21.71% | -114.88% |
| Sep 16, 2026 | $0.07 | -93.92% | $273.41 | +18.14% | -112.06% |
| Sep 15, 2026 | $0.04 | -95.94% | $272.88 | +17.91% | -113.85% |
| Sep 14, 2026 | $0.05 | -95.90% | $273.11 | +18.01% | -113.91% |
Page 1 of 5